Association of medical insurance and other factors with receipt of antiretroviral therapy
Association of medical insurance and other factors with receipt of antiretroviral therapy
复制标题
DOI：
10.2105/ajph.92.5.852
复制
发表时间：
2002-05-01
影响因子：
12.7
通讯作者：
Moore, RD
中科院分区：
文献类型：
--
作者：
Keruly, JC;Conviser, R;Moore, RD
目的：本研究旨在评估与接受高效抗逆转录病毒治疗（HAART）相关的社会人口学和医疗保险因素。纳入的患者（n = 959）于1996年4月1日之后在约翰霍普金斯HIV诊所登记，接受了大于或等于90天的护理。CD 4计数≥ 500个/mm 3或HIV-1 RNA > 20000拷贝/mL。我们评估了社会人口因素和医疗保险与接受HAART的关系。按2个时间段分层（1996年4月至1997年3月与1997年4月至1999年3月），结果。HAART更可能用于>39岁的患者。白色，CD 4计数
Objectives, This study was designed to assess sociodemographic and medical insurer factors associated with receipt of highly active antiretroviral therapy (HAART).Methods. Patients included (n = 959) were enrolled in the Johns Hopkins HIV Clinic after April 1, 1996, received greater than or equal to90 days of care. and had a CD4 count greater than or equal to500 cells/mm(3) or HIV-1 RNA >20 000 copies/mL. We assessed the associations of sociodemographic factors and medical insurance with receipt of HAART. stratified by 2 time periods (April 1996 through March 1997 versus April 1997 through March 1999),Results. HAART was more likely to be used in patients who were >39 years. White, had CD4 counts